EPRX
Price
$3.04
Change
+$0.03 (+1.00%)
Updated
Jan 14 closing price
Capitalization
107.64M
76 days until earnings call
JWCTF
Price
$0.16
Change
-$0.00 (-0.00%)
Updated
Dec 27 closing price
Capitalization
69.83M
Ad is loading...

EPRX vs JWCTF

Header iconEPRX vs JWCTF Comparison
Open Charts EPRX vs JWCTFBanner chart's image
Eupraxia Pharmaceuticals
Price$3.04
Change+$0.03 (+1.00%)
Volume$5.28K
Capitalization107.64M
JW CAYMAN THERAPEUTICS
Price$0.16
Change-$0.00 (-0.00%)
Volume$200
Capitalization69.83M
EPRX vs JWCTF Comparison Chart
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. JWCTF commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and JWCTF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (EPRX: $3.04 vs. JWCTF: $0.16)
Brand notoriety: EPRX and JWCTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 33% vs. JWCTF: 17%
Market capitalization -- EPRX: $107.64M vs. JWCTF: $69.83M
EPRX [@Biotechnology] is valued at $107.64M. JWCTF’s [@Biotechnology] market capitalization is $69.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileJWCTF’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • JWCTF’s FA Score: 1 green, 4 red.
According to our system of comparison, JWCTF is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 3 TA indicator(s) are bullish while JWCTF’s TA Score has 4 bullish TA indicator(s).

  • EPRX’s TA Score: 3 bullish, 5 bearish.
  • JWCTF’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, JWCTF is a better buy in the short-term than EPRX.

Price Growth

EPRX (@Biotechnology) experienced а -0.33% price change this week, while JWCTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

EPRX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EPRX($108M) has a higher market cap than JWCTF($69.8M). JWCTF YTD gains are higher at: 0.000 vs. EPRX (-4.101).
EPRXJWCTFEPRX / JWCTF
Capitalization108M69.8M155%
EBITDA-27.76MN/A-
Gain YTD-4.1010.000-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash8.66MN/A-
Total Debt93KN/A-
TECHNICAL ANALYSIS
Technical Analysis
EPRXJWCTF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 8 days ago
63%
Bullish Trend 8 days ago
38%
Momentum
ODDS (%)
Bearish Trend 8 days ago
71%
Bullish Trend 8 days ago
48%
MACD
ODDS (%)
N/A
Bullish Trend 8 days ago
36%
TrendWeek
ODDS (%)
Bearish Trend 8 days ago
65%
Bullish Trend 8 days ago
30%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
54%
Bearish Trend 8 days ago
65%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
N/A
BollingerBands
ODDS (%)
Bullish Trend 8 days ago
67%
Bullish Trend 8 days ago
58%
Aroon
ODDS (%)
Bearish Trend 8 days ago
27%
Bearish Trend 8 days ago
73%
View a ticker or compare two or three
Ad is loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JWCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
GRT.X0.2037780.010625
+5.50%
The Graph cryptocurrency
MEME.X0.0091350.000433
+4.98%
Memecoin cryptocurrency
WAN.X0.2039000.008987
+4.61%
Wanchain cryptocurrency
ARK.X0.645105-0.009365
-1.43%
Ark cryptocurrency
MFT.X0.005822-0.000597
-9.30%
Mainframe cryptocurrency

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with CRBU. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+1.16%
CRBU - EPRX
41%
Loosely correlated
+0.65%
ACAD - EPRX
27%
Poorly correlated
-5.59%
KRON - EPRX
21%
Poorly correlated
+3.13%
ATHA - EPRX
21%
Poorly correlated
+0.17%
LEXX - EPRX
21%
Poorly correlated
-6.31%
More

JWCTF and

Correlation & Price change

A.I.dvisor tells us that JWCTF and HSITF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JWCTF and HSITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JWCTF
1D Price
Change %
JWCTF100%
N/A
HSITF - JWCTF
25%
Poorly correlated
N/A
HCWB - JWCTF
12%
Poorly correlated
-5.93%
SRZN - JWCTF
8%
Poorly correlated
-1.15%
INDP - JWCTF
5%
Poorly correlated
-5.24%
EPRX - JWCTF
4%
Poorly correlated
+1.16%
More